In the current study, we measured diverse characteristics of tissue TAMs, including CCL20 and other cytokines by multicolor immunofluorescence and single-cell analysis, and correlated them with the clinical outcome of cutaneous melanoma patients. This evidence concerns the gene CCL20 and cutaneous melanoma.